1. Home
  2. GHRS vs TWFG Comparison

GHRS vs TWFG Comparison

Compare GHRS & TWFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • TWFG
  • Stock Information
  • Founded
  • GHRS 2018
  • TWFG 2001
  • Country
  • GHRS Ireland
  • TWFG United States
  • Employees
  • GHRS N/A
  • TWFG N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • TWFG
  • Sector
  • GHRS Health Care
  • TWFG
  • Exchange
  • GHRS Nasdaq
  • TWFG NYSE
  • Market Cap
  • GHRS 583.1M
  • TWFG 520.9M
  • IPO Year
  • GHRS 2021
  • TWFG 2024
  • Fundamental
  • Price
  • GHRS $12.03
  • TWFG $35.01
  • Analyst Decision
  • GHRS Strong Buy
  • TWFG Buy
  • Analyst Count
  • GHRS 8
  • TWFG 8
  • Target Price
  • GHRS $30.63
  • TWFG $33.71
  • AVG Volume (30 Days)
  • GHRS 149.3K
  • TWFG 64.0K
  • Earning Date
  • GHRS 05-08-2025
  • TWFG 05-13-2025
  • Dividend Yield
  • GHRS N/A
  • TWFG N/A
  • EPS Growth
  • GHRS N/A
  • TWFG N/A
  • EPS
  • GHRS N/A
  • TWFG N/A
  • Revenue
  • GHRS N/A
  • TWFG $211,440,000.00
  • Revenue This Year
  • GHRS N/A
  • TWFG $22.67
  • Revenue Next Year
  • GHRS N/A
  • TWFG $20.74
  • P/E Ratio
  • GHRS N/A
  • TWFG N/A
  • Revenue Growth
  • GHRS N/A
  • TWFG 18.57
  • 52 Week Low
  • GHRS $6.00
  • TWFG $21.31
  • 52 Week High
  • GHRS $20.50
  • TWFG $36.67
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 58.82
  • TWFG N/A
  • Support Level
  • GHRS $10.66
  • TWFG N/A
  • Resistance Level
  • GHRS $13.00
  • TWFG N/A
  • Average True Range (ATR)
  • GHRS 0.96
  • TWFG 0.00
  • MACD
  • GHRS 0.12
  • TWFG 0.00
  • Stochastic Oscillator
  • GHRS 67.84
  • TWFG 0.00

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About TWFG TWFG INC

TWFG Inc is a independent distribution platform for personal and commercial insurance in the United States. It offers all lines of insurance, multiple distribution contract options, M&A services, proprietary virtual assistants, proprietary technology, proprietary premium financing, unlimited continuing education, recognition programs, co-op funding, marketing support and overall lower costs to operate.

Share on Social Networks: